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Objectives: An audit of treating femoro-crural bypass stenosis in the first instance by PTA. 
Design: Prospective clinical pilot study in consecutive patients. 
Materials: Prior to vascular bypass grafting all patients had critical ischaemia. Sixty-four PTA procedures in 50 grafts 
in 49 patients were carried out. Thirteen were in situ saphenous grafts, 16 were combined venous segments, 18 were 
combined PTFE and vein and three were PTFE only. 
Methods: Conventional cross-over or antegrade PTA, eventually combined with local thrombolytic therapy. 
Results: The nine-month assisted patency using PTA was 72%,following surgical repair in five cases after failed PTA 
the secondary patency was 86%. The amputation free survival rate was 88%. In 11 cases thrombosis was treated 
successfully with local thrombolysis. In two cases the balloon ruptured the native artery wall below the distal anastomosis 
with pseudoaneurysm formation. Six limbs were amputated uring follow-up. The frequency of stenosis in combined 
grafts was significantly higher than in in situ vein grafts. 
Conclusion: Our results are comparable with surgery. About 600 hospital beds/days were saved. This shortened the time 
from the diagnosis of stenosis to therapy and shortened the waiting list for vascular surgery. 
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Introduction 
It is ou r impression that most graft stenosis are treated 
by surgical revision -a t  least in our country. In a 
number of studies PTA was used preferentially on 
short lesions. 1-11 Only one centre 12'1s has reported series 
where percutaneous transluminal ngioplasty was the 
first choice in consecutive patients. The present hos- 
pital has a long tradition of using PTA on infrainguinal 
arteries. ~4 Therefore, a pilot study of treating graft 
stenoses in consecutive patients with vein and pros- 
thetic grafts was conducted. 
Material and Methods 
From February 1995 to February 1996 we successfully 
performed 209 below-knee bypasses. The indications 
were critical imb ischaemia in all cases. One-hundred 
and twenty-seven (61%) were in in situ saphenous 
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vein grafts, and 82 (39%) were combined vein segments 
or vein and PTFE. Of the 127 patients who had in situ 
bypass surgery, only nine patients (7%) developed 
stenosis, while in the 82 patients who had combined 
grafts with or without PTFE, 21 patients (26%) de- 
veloped stenosis (p<0.003). Stenoses were found in 
nineteen patients who had bypass urgery in previous 
years. All together, stenoses were found in 50 grafts 
in 49 patients (Table 1). Patients with occluded grafts 
during the first 6 weeks after vascular surgery were 
excluded from the present study. This study included 
25 women and 24 men. The median age was 73 years 
(range 27-90 years) and thirty-nine (80%) of the 
patients had diabetes. The bypass stenoses were ,all 
treated in the first instance with PTA. Before treatment 
Table 1. Graft material. 
In situ bypass 13 
Combined vein segments 16 
PTFE combined with segment ofvein 18 
PTFE with Miller-cuff 1 
PTFE 2 
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Table 2. Ipsilateral surgery on 49 patients before PTA on graft 
stenosis. 
Surgery n 
Bypass grafts: once 
Bypass grafts: twice 
Bypass grafts: three times 
Bypass grafts: five times 
Number of jump grafts 
Ligation of a-v fistulas 
Femoral-femoral cross-over 
Above knee bypass 
Aorto-femoral bypass 
Thrombectomy 
Toe or forefoot amputation 
Chopart amputation 
Resection of achilles tendon and calcaneous 















Table 3. Graft position. 
Proximal anastomosis 
Common femoral artery 
Superficial femoral artery 
Deep femoral artery 






Infragenicular popliteal artery 10 
Anterior tibial artery 18 
Posterior tibial artery 11 
Fibular artery 5 
Dorsal pedal artery 6 
these 49 patients had had 103 surgical procedures 
(Table 2). The position of the grafts are listed in Table 
3. 
Following vascular surgery all patients underwent 
graft surveillance at 10 days, 6 weeks then 3-monthly 
for the first year, 6-monthly for the second year and 
yearly to 5 years. Patients were assessed clinically and 
by measurement of resting ankle (AI) and toe blood 
pressure index (TI) using the strain gauge technique. 
The grafts were examined with colour coded duplex 
scanning (CD) using a 5 or a 7 MHz probe (Quantum 
2000, Siemens, U.S.A.) during the first 2 years and if 
the distal blood pressure deteriorated at the later 
fol low-up examinations. The entire graft was scanned. 
Significant stenoses were diagnosed if the char- 
acteristic peak velocity increased by a factor of 2.5 or 
more over a short segment. 
The graft stenoses were detected by duplex scanning 
in 44 (88%) and by a drop in AI and TI in six cases. 
In three cases the stenoses were not seen by the 
subsequent angiography, but demonstrated at re- 
peated duplex scanning. 
The max imum peak flow velocity increase at the 
stenoses ranged from 2.5 to 10 times, median 3.5. The 
Table 4. Site of 69 graft stenoses treated with 64 PTA procedures. 
No. 
Proximal anastomosis 2 
Body of graft 20 
Distal anastomosis 30 
Jump graft anastomosis 5 
R~m-off artery 10 
Kink on PTFE 2 
Table 5. Distal pressure measurements. 
AI TI 
Before vascular (mean + S.D.) 0.32+0.15 0.90_+0.09 
surgery 
Six weeks after (mean ± S.D.) 0.87 + 0.18 × 0.50 ± 0.15 x
vascular surgery 
Time of diagnosis of (mean ± S.D.) 0.76 ± 0.20 x 0.42 ± 0.21 °
stenosis 
Following PTA (mean ± S,D.) 0.89 ± 0.18 x 0.63 ± 0.22 x
AI = Ankle/arm blood pressure index, TI = Toe/arm blood pressure 
index. 
x indicates asignificant change compared to baseline (p<0.001) 
o indicates asignificant change compared to baseline (p<0.05) 
max imum flow velocity along the graft was in nine 
cases less than 35 cm/s.  In 34 grafts one stenosis was 
detected, in 14 grafts two stenoses, in one case three, 
and in one case four stenoses were detected. The site 
of the stenosis is seen in Table 4. The length of the 
stenoses were median I cm, with a range from 0.2 to 
7 cm. Sixteen graft stenoses were from 2 to 7 long. The 
distal blood pressures had dropped significantly from 
the postoperative measurements at 10 days or at 6 
weeks to the time of the diagnosis of stenoses for the 
whole group of patients (Table 5). In 23 patients the AI 
pressure drop exceeded 0.20 (range 0.21-0.60). Three 
patients had relapse of rest pain, three patients had 
developed gangrene of the heel. Eight stenoses were 
demonstrated at the second postoperative month, 24 
stenoses were demonstrated from 2-5 months, 22 sten- 
oses from the sixth month to 1 year, eight stenoses in 
the second year and two stenoses until the fourth year. 
Grafts in which intervention was considered were 
assessed further by intra-arterial digital subtraction 
angiography. In a few cases of obviously failing grafts, 
PTA was carried out during the same procedure. Fol- 
lowing PTA the non-invasive tests described above 
were repeated at 1 day, 10 days and 6 weeks, after 
which the original fol low-up schedule was followed. 
If these early examinations were unsatisfactory, angio- 
graphy was repeated and repeat PTA or revision sur- 
gery was undertaken. The median time from surgery 
to PTA was 6 months (range six weeks to 51 months). 
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The median time from diagnosis to PTA was 12 days 
(range 0-78 days). Following PTA the distal pressures 
reached postoperative alues (Table 5). 
Statistics 
Assisted primary patency was defined as un- 
interrupted patency but allowed procedures to be 
performed on a patent bypass graft to prevent its 
eventual thrombosis. Secondary patency required that 
flow was restored through most of the original graft 
including at least one of the original anastomosis. Data 
were analysed using Mann-Whitney U-Test, Fischer's 
exact test and the life table method. Statistical sig- 
nificance was assumed at the 95% confidence level 
(p<0.05). 
Interventional procedures 
The lesions were approached from the contralateral 
groin for stenoses in the proximal third of the graft 
and from the ipsilateral groin for more distal stenoses. 
Heparin 70 IU/kg i.a. was administered and i.a. gly- 
ceryl nitrate 100-200 ~tg was repeated in cases with 
spasms of the graft or the run-off artery. Where throm- 
bosis occurred in the run-off artery during dilatation 
of the stenoses, thrombolytic therapy was delivered 
using the balloon catheter (10-20 mg of tissue plas- 
m inogen activator (Actilyse ® Boehringer Ingelheim, 
Germany). Following PTA it was not possible to assess 
the residual stenosis where a relatively large graft 
was anastomosed to a small native tibial artery and 
therefore these measurements were not recorded. 
Results 
Forty of the 50 grafts (80%) were successfully treated by 
PTA on one occasion. In all these grafts the previously 
abnormal f ow determined by CD returned to normal 
after angioplasty at the first or 10th day after PTA. 
Six grafts required two dilatations and four grafts 
underwent three dilatations. The second and third 
angioplasties were performed from 14 days to 7 
months after the first dilatation. All restenoses were 
located at the distal anastomosis. In a further two 
grafts the balloon chosen was too small at the first 
procedure and in one graft the balloon could not 
be placed at the stenosis. In one graft with a distal 
anastomotic stenosis as well as a stenosis at the level 
of the knee, the dilatation of the first lesion was 
successful. The second lesion was corrected surgically 
and was then found to be caused by external com- 
pression from the pes anserinus. In two cases new 
stenoses were found at the second PTA. At two pro- 
cedures an over-sized balloon caused arterial rupture 
and pseudoaneurysm formation of the run-off arteries. 
One of these cases resulted in amputation. The other 
was treated conservatively and follow-up duplex scan- 
ning at 6 weeks demonstrated thrombosis of pseudo- 
aneurysm and a patent graft. 
Following dilatation, the run-off artery was found 
to be thrombosed in 10 cases. Infusion of recombinant 
tissue plasminogen activator (rt-PA) 10-20 mg through 
the indwelling balloon catheter into the thrombus 
resulted in successful lysis in all cases within i h. 
Intravascular thrombi were suspected in four ad- 
ditional cases and were treated successfully with 
rt-PA. 
Two distal anastomoses thrombosed within 24 h. 
Both thromboses occurred at the site of dilatation, 
the grafts were still open, and successful surgical 
reconstruction was therefore possible. 
There were six late graft occlusions. Five grafts were 
in part PTFE and the sixth was an in situ graft which 
had previously had two jump grafts because of distal 
anastomotic stenosis. Two patients with known re- 
stenosis failed to attend the surveillance program, and 
the grafts occluded 40 and 60 days after PTA. Two 
grafts had a kink of the PTFE and a distal anastomofic 
stenosis. The stenoses were dilated and the kink was 
straightened out, but the grafts occluded 3 and 6 
months after PTA. These were the only two lesions 
situated in a segment of PTFE. Two further grafts 
occluded 6 months after PTA without a known sten- 
osis. 
Five patients had a surgical graft revision after PTA. 
In one case the balloon could not be placed at the 
stenosis and a successful surgical repair was per- 
formed. One patient had a 7 cm long stenosis in the 
anterior tibial artery and at the anastomosis. The artery 
was dilated twice and at the second procedure the 
artery ruptured with formation of a pseudoaneurysm. 
A jump graft was constructed, but because of pro- 
gressive wound complication an amputation was re- 
quired. As previously mentioned, the two patients 
with early occlusion at the site of dilatation had a 
successful surgical revision. Finally, one patient who 
had external compression from the pes anserinus was 
successfully treated by dividing the fibres. There were 
six amputations. One patient with a composite graft 
restenosis and a P.S.V. ratio of 5 was observed at the 
6 weeks' surveillance after PTA. She was lost to 
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months  after PTA w i th  no known stenosis. Two 
pat ients  were  amputated  wi th  patent  grafts. One was  
the pat ient  who had  surgery  fo l lowing arter ia l  rupture  
and progress ive  wound compl icat ions.  The second 
pat ient  had  lost a foot due to heel  gangrene.  The sixth 
pat ient  had  fai led vascu lar  surgery  fo l lowing occlus ion 
6 months  after PTA. 
With  a min imum of 3 months '  survei l lance to May  
1996, l i fe-table calculat ions (Fig. 1) showed an ass isted 
pr imary  patency  of 72% fo l lowing PTA. Add i t iona l  
surgery  showed a secondary  patency  of 86%. Chi-  
squared  test showed no difference. The med ian  in 
hospi ta l  t ime for all pat ients  t reated w i th  PTA was  1.8 
days.  In 1993, where  all lesions were  t reated surgica l ly  
the med ian  hosp i ta l  stay was  14 days.  
Fig. 1. Patency curves. The dashed line showes the patency following 
PTA, and the continuous line shows the patency of PTA followed 
by surgery. (--) PTA only; ( - - )  PTA followed by surgical revision. Discussion 
fo l low-up and 2 months  later the graft occ luded and 
amputat ion  was  per formed.  Another  pat ient  who had  
a PTFE graft  w i th  a Mi l ler  cuff deve loped a restenosis  
w i th  a f low increase of 3.7 at the Mi l ler  cuff at 6 weeks '  
survei l lance.  The PTA was  de layed  40 days  and  the 
graft  occ luded.  Fur ther  revascu lar isat ion was  not  pos-  
sible. One pat ient  who was  reconstructed three t imes 
f inal ly w i th  combined  ve in  and  PTFE occ luded 8 
The l i terature on the t reatment  of graft  stenosis is 
shown in Table 6a and  b. Table 6a detai ls  the studies 
where  surgery  was  pre fer red  or was  the on ly  form of 
correct ion of stenosis. In Table 6b the studies are where  
both  PTA and surgery  were  used.  In some of these 
latter studies PTA was  on ly  used  for shorter  lesions, 
e.g. less than 3 or 5 cm. However ,  we  found no dif- 
ference in the fai lure rate in short  and  long stenosis. 
Table 6a. Authors not favouring PTA of graft stenosis. 







Thompson et al. PTA 14 Rest. 6 months 
Surgery 14 100% 13 months 
Perler et aL PTA 19 29% 12 months 
Surgery 9 55% 6 months 
Green et al. PTA - -  
Surgery 18 86% 12 months 
Bandyk et aL PTA 18 85% 12 months 
Surgery 85 85% 12 months 
Whittemore et al. PTA 30 18% 5 years 
Surgery - -  
Lundeli et al. PTA - -  - -  
Surgery 56 78% 3 years 
Table 6b. Authors favouring PTA of graft stenosis. 






Moody et al. PTA 18 100% 12 months 
Surgery 6 100% 12 months 
Taylor et al. PTA 13 46% 12 months 
Surgery 17 64% 12 months 
Sanchez et al. PTA 65 58% 5 years 
Surgery 51 71% 5 years 
Sanchez et al. PTA 40 Comple- 4 years 
Surgery 100 mentary 4years 
Wilson et aL PTA 40 Comple- 4 years 
Surgery 20 mentary 4 years 
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The two cases of kinking of PTFE both occluded. Apart 
from the two latter cases the pathological lesions in 
our material must be of the same nature as in the 
studies listed in Table 6. 
A difference may be observed between the studies 
of both Perler et al. 2 and Whittemore t al. 5 where the 
time from vascular surgery to PTA was 17 months, 
compared to the study of London et al. 12 and the 
present study, where the time from vascular surgery 
to PTA was only 6 months. In addition, in the two 
latter studies only a few patients were symptomatic, 
whilst all patients in the Perler and Whittmore studies 
had symptoms of relapse. These observations suggest 
that early detection and correction of graft stenosis by 
PTA will be successful, while late treatment of graft 
stenosis is of less benefit when treated with PTA. 
Thompson et al. 1 treated 14 stenoses using PTA, and 
all required surgical revision within 6 months. Green 
et aI. 3 found 18 graft stenoses and surgical revision 
was carried out in all with a 1-year patency of 86%. 
In the study of Bandyk eta[. 4 103 stenoses were treated, 
85 by surgical revision and 18 by PTA. Of these 18 
procedures only five were graft stenoses; 13 procedures 
were on run-in or run-off vessels. There was only one 
case of graft failure in the cases treated with PTA. 
In these studies 1'3'4 the authors obviously preferred 
surgery but did not demonstrate failure of PTA to 
treat graft stenoses. 
Moody et al. 7 treated eight stenoses with PTA and 
10 by surgical revision. No repeat PTA was necessary 
and at 1 year all were patent. At St. Mary's Hospital s
surveillance showed 41 haemodynamically significant 
stenoses. Thirteen were treated with PTA. There were 
two immediate and two late occlusions. Three stenoses 
recurred. Surgical revision seemed more successful, 
but the authors state that "web" stenosis may be 
treated successfully by balloon dilatation. Sanchez et 
al. 19919 treated 71 lesions shorter than 5 cm by PTA 
and the 1-year patency was 89%. Seventy-one stenoses 
longer than 5 cm and PTA failures had surgical revision 
with a 1-year patency of 89%. In this study vein grafts, 
PTFE and composite grafts were treated. In the study 
by Sanchez 19931° the graft was only PTFE. Only 
lesions shorter than 2 cm in the in- and outflow vessels 
were treated by PTA. There results were still about 
90% 1-year patency independent of whether surgical 
revision or PTA was used. Wilson et al. 11 found a 1- 
year primary assisted and secondary patency after 
PTA and surgical revision of 77% and 84%, re- 
spectively. These figures are very similar to the present 
study. Taylor et aI. 8 divided graft stenosis into haemo- 
dynamic and non-haemodynamic lesions. The latter 
were defined as a lesion giving rise to a local rise 
in peak flow velocity between 50% and 100%. No 
procedure was undertaken in 24 grafts with non- 
haemodynamic stenosis. Three of these grafts occluded 
(13%), indicating that even these lesions carry a sub- 
stantial risk of occlusion. 
This series has shown that local thrombosis is a 
frequent complication following PTA of graft stenoses, 
i.e. it occurred in 22% of the procedures and was 
only observed in low flow grafts. Local thrombolysis, 
however, is efficacious, since all cases remained open. 
The reason why we observed thrombosis in the tibial 
arteries during the procedures in nine cases, in spite 
of heparin, is partly explained by the very low blood 
flow which was stopped completely by balloon-in- 
flation. Our program with duplex scanning at day 1 
and day 10 after PTA revealed complications which 
required correction in 10% of the cases. 
Our 9 months' patency rate of 72% using PTA com- 
pares favourably with surgery and speaks in favour 
of conducting controlled trials. The median hospital 
time for PTA procedures was 1.8 days compared to 
14 days (median) following surgical revisions, and 
represents a saving of about 600 hospital days during 
1 year. 
Conclusion 
PTA is efficient in treating graft stenoses in patients 
with occlusive arterial disease of the legs. The early 
patency results in vein grafts are similar to results in 
prosthetic grafts. Surveillance at day 1 and day 10 
after the PTA procedure revealed two cases of pseudo- 
aneurysm, one case of persistent stenosis caused by 
external compression by a tendon, two cases of early 
thrombosis, and two cases where too small a balloon 
had been chosen. 
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